No Data
No Data
Eli Lilly, Novo Under Pressure as Biden Urges Lower Drug Prices
AstraZeneca (AZN) Receives a Hold From Jefferies
Express News | AstraZeneca : Jefferies Raises Target Price to $74 From $71
AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
The European Medicines Agency (EMA) has accepted AstraZeneca Plc's (NASDAQ:AZN) marketing authorization application for sipavibart for pre-exposure prophylaxis (prevention) of COVID-19 in immunocompro
AstraZeneca Shares Update and Global Reach
Express News | AstraZeneca's Marketing Authorization Application For Sipavibart Has Been Accepted Under An Accelerated Assessment Procedure By The European Medicines Agency, For The Pre-exposure Prophylaxis (Prevention) Of Covid-19 In Immunocompromised Patients